StockData
Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp. (MDNAF) income statement

MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2023, năm kết thúc ngày Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)

Close on Oct 19, 2026

Medicenna Therapeutics Corp. income statement

Ratios

Latest available, balances at Mar 31, 2023

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2023
–

Financial strength

Current ratio
9.57
Debt to equity
–
Debt to assets
–
Cash to current liabilities
884.1%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

Valuation ratios need the share price and fill in once daily prices are connected.

See a number that looks wrong?